5PSQ-093 Assessment tool for hospital admissions related to medications 10 questions (at-harm10): a validation study

摘要

The MedBridge study, with the aim of evaluating the effects of comprehensive medication reviews performed by ward-based clinical pharmacists on elderly patients’ healthcare consumption, started in February 2017. A secondary outcome measure in the study will be drug-related admissions (DRAs) during the follow-up year. As the identification of DRAs inevitably has a degree of subjectivity, a reliable and standardizsed method is required. The involvement of senior clinicians is often deemed necessary, making the assessment relatively expensive. We therefore developed an Assessment Tool for Hospital Admissions Related to Medications, consisting of 10 questions (AT-HARM10), which could be used by less experienced clinical pharmacists and advanced pharmacy students instead.